Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Receivables (2016 - 2025)

Rockwell Medical's Receivables history spans 16 years, with the latest figure at $8.1 million for Q4 2025.

  • For Q4 2025, Receivables fell 1.79% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $8.1 million, down 1.79%, while the annual FY2025 figure was $8.1 million, 1.79% down from the prior year.
  • Receivables reached $8.1 million in Q4 2025 per RMTI's latest filing, down from $8.3 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $16.2 million in Q2 2022 to a low of $5.4 million in Q2 2023.
  • Average Receivables over 5 years is $10.2 million, with a median of $10.2 million recorded in 2021.
  • Peak YoY movement for Receivables: plummeted 66.56% in 2023, then soared 100.33% in 2024.
  • A 5-year view of Receivables shows it stood at $11.8 million in 2021, then plummeted by 47.07% to $6.3 million in 2022, then soared by 74.17% to $10.9 million in 2023, then dropped by 23.94% to $8.3 million in 2024, then dropped by 1.79% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Receivables are $8.1 million (Q4 2025), $8.3 million (Q3 2025), and $8.1 million (Q2 2025).